TNF Pharmaceuticals - TNFA Operatsion rentabellik

TNFA (TNF Pharmaceuticals Inc.) - kompaniyaning tovar belgisi

TNF Pharmaceuticals o'z laboratoriyalarida bio-chiqindilarni minimallashtirish orqali ekologik standartlarga rioya qiladi. TNF Pharmaceuticals o'zining patent portfeli orqali raqobatlashgan holda, noyob yallig'lanishga qarshi usullarni ishlab chiqmoqda. Biroq, barqaror daromadning yo'qligi va sinovlarning muvaffaqiyatsizligi xatarlari qadrsizlanish tahdidini yuzaga keltirmoqda. GURU.Markets terminali asosiy biznes marjasining grafigini namoyish etadi, bunda 0.00 eng so'nggi metrika qiymatini aks ettirib, biznesning barqarorligini baholashga yordam beradi.

TNFA: TNF Pharmaceuticals Inc. Operatsion foyda normasi 25.07.2024 - 25.09.2025

TNF Pharma - tahliliy kesimlar va asosiy koʻrsatkichlar (TNFA)

Kompaniyaning har tomonlama tahlili:tnfpharma.com, TNFA
TNF Pharmaceuticals Inc. asosiy tovari

Ushbu ko'rsatkich operatsion foydaning umumiy daromadga nisbatini o'lchaydi, bu esa qarz majburiyatlari va soliqlarni hisobga olishdan oldin ishlab chiqarish jarayoni samaradorligini baholash imkonini beradi. Asosiy biznes marjasining tahlili TNF Pharmaceuticals (TNFA) kompaniyasining tadqiqot va ishlanmalar (R&D) xarajatlari bilan tijorat mahsulotlarining yo'qligi o'rtasidagi jiddiy tafovutni ochib beradi, bu esa biotexnologiya startapining o'ziga xos tabiati tufayli joriy operatsion samaradorlikni salbiy holatga keltirmoqda.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda normasi PTHL (Pheton Holdings)|Aptorum (APM) - Operatsion rentabellik|LYRA (Lyra Therapeutics) - Operatsion rentabellik|Operatsion rentabellik Impact BioMedical Inc|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.